"It’s important that the early vaccines are distributed in a fair, ethical and transparent way," said Redfield, adding that they are working on recommendations on how to prioritize different populations when it comes to distributing a vaccine.
The US, which has invested more than $10 billion in six potential vaccines through Operation Warp Speed, is working with drugmakers to ramp up manufacturing so a vaccine can be rolled out quickly and to as many people as possible. US officials said companies have made “hundreds of thousands” of doses for the US so far.
Paul Mango, deputy chief of staff for policy in the Department of Health and Human Services, said some of the vaccines require two doses at varying intervals, while others require one, which paired with other factors present logistical challenges of distributing a vaccine.
The CDC’s guidelines for distributing a vaccine propose "groups for early phase vaccination" to include health-care workers, essential personnel and vulnerable Americans, such as the elderly and people with underlying health conditions.
Mango said that once a vaccine has been distributed, federal health officials will continue tracking those who receive it for potential side effects, adding that "the vaccine could be pulled from the market if the data suggests something that is adverse there."
To read more NewsPoints articles, click here.